Dr. Richard Wintle

Dr. Wintle, PhD, trained in Molecular and Medical Genetics at the University of Toronto, studying the organization of antibody genes. His postdoctoral training at the Centre for Addiction and Mental Health (Toronto) focused on the dopamine signaling in the nervous system of a simple model organism, the roundworm C. elegans. He then worked in a scientific operations role with two related biotechnology companies, managing research programs focused on the genetics of inflammatory diseases including Crohn's Disease and Rheumatoid Arthritis. Since January of 2006, he has been Assistant Director of The Centre for Applied Genomics (TCAG) at The Hospital for Sick Children in Toronto, Canada, a facility specializing in genome sequencing and analysis for thousands of investigators across Canada and around the world. He is a founding member of the Governance Council of the International CP Genomics Consortium, and acts as Executive Director of HPC4Health, a high performance computing facility designed for the analysis of healthcare research data. His current research focuses on using genome sequencing to understand how genes can contribute to CP and other neuromotor disorders.